Hineline Lawrence J. — SEC Form 4 filings
SEC reporting owner CIK 1585697. 5 Form 4 filings on record with FilingPulse; latest filed 2024-03-11.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-02-05 to 2024-03-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 3 filings — 47,773 shares, $3,213,145 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 10,998 shares @ $66.61 ($732,577) in Intra-Cellular Therapies, Inc., filed 2024-02-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) | SVP of Finance, CFO | 5 | — | 14 legs · 47,773 sh · $3,213,145 | 12 |
Form 4 filings — Hineline Lawrence J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-03-11 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Sale (S): 6,514 @ $66.26 · Sale (S): 6,618 @ $66.93 · Option exercise (M): 5,582 · Sale (S): 4,453 @ $65.28 · Sale (S): 1,100 @ $66.54 · Sale (S): 29 @ $67.32 · +5 more | EDGAR |
| 2024-03-08 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 13,132 · Option exercise (M): 13,132 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/award (A): 26,227 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 7,455 · Sale (S): 300 @ $68.33 · Sale (S): 6,867 @ $69.38 · Sale (S): 288 @ $70.15 · Option exercise (M): 5,882 @ $36.89 · Sale (S): 5,282 @ $69.47 · +3 more | EDGAR |
| 2024-02-05 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/award (A): 11,183 @ $0 · Sale (S): 10,998 @ $66.61 · Sale (S): 185 @ $67.35 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1585697 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →